Genestie C, Zafrani B, Asselain B, Fourquet A, Rozan S, Validire P, Vincent-Salomon A, Sastre-Garau X
Department of Pathology, Institut Curie, Paris, France.
Anticancer Res. 1998 Jan-Feb;18(1B):571-6.
The most commonly used system in Europe for breast carcinoma was developed by Scarff, Bloom and Richardson (SBR). It was recently modified by Elston and Ellis and significant improvement in reproducibility has been shown by using precise grading guidelines. This study investigated whether the use of this new grade (defined as the Nottingham grade, NG) would improve the prognostic stratification of patients. The respective prognostic value of the two grading schemes was compared in a retrospective series of 825 patients uniformly treated for a small invasive breast carcinoma and followed for a median of 6 years. Univariate and multivariate analysis showed that both histological grades were strongly correlated to overall and metastasis free survival. We have separately analysed the prognostic value of each of the three components used to assess the two grading systems and found that the mitotic index was the only significant prognostic factor for 5 year survival. Univariate analysis showed the count to be more discriminant in the NG scheme (p = 0.0006) than in the SBR scheme (p = 0.04). However, in univariate and multivariate analysis, the prognostic value of the global NG was not significantly better than SBR grade. This may be related, in part, to an uneven distribution of cases reflected by a much lower number of cases with a high mitotic index in the NG system (2%) than in the SBR system (10%). Our study emphasizes the importance of the mitotic count in assessing the prognosis of breast cancers and indicates that the factors which condition this count (tissue processing, microscopic observation, threshold) must be well standardized and controlled.
欧洲最常用的乳腺癌分级系统是由斯卡夫、布鲁姆和理查森(SBR)开发的。最近,埃尔斯顿和埃利斯对其进行了修改,通过使用精确的分级指南,已显示出在可重复性方面有显著改善。本研究调查了使用这种新分级(定义为诺丁汉分级,NG)是否会改善患者的预后分层。在一组825例均接受小浸润性乳腺癌治疗且中位随访6年的回顾性系列研究中,比较了两种分级方案各自的预后价值。单因素和多因素分析表明,两种组织学分级均与总生存期和无转移生存期密切相关。我们分别分析了用于评估两种分级系统的三个组成部分各自的预后价值,发现有丝分裂指数是5年生存率的唯一显著预后因素。单因素分析显示,该计数在NG方案(p = 0.0006)中比在SBR方案(p = 0.04)中更具鉴别力。然而,在单因素和多因素分析中,整体NG的预后价值并不显著优于SBR分级。这可能部分与病例分布不均有关,表现为NG系统(2%)中高有丝分裂指数的病例数远低于SBR系统(10%)。我们的研究强调了有丝分裂计数在评估乳腺癌预后中的重要性,并表明影响该计数的因素(组织处理、显微镜观察、阈值)必须得到很好的标准化和控制。